Insmed director gifts 100 shares of common stock

INSMED Inc director Melvin Sharoky, MD reported a bona fide gift of common stock.

Accepted by SEC EDGAR 03/05/2026 - 04:15 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

INSMED Inc director Melvin Sharoky, MD reported a bona fide gift of common stock. On March 3, 2026, an entity associated with him transferred 100 shares of common stock as a gift transfer at a reported price of $0.0000 per share, reducing his directly held shares to 242,776.

He also reported several indirect holdings: 6,847 shares held by his spouse, 5,000 shares held by Padonia, LLC, where he is the managing member, and custodial UTMA/FL accounts holding 819, 5,423, 5,007, and 3,724 shares for named family beneficiaries.

Insider Trade Summary

100 shares gifted

Gift 1 txn

Insider SHAROKY MELVIN MD

Role Director

Type	Security	Shares	Price	Value
Gift	Common Stock	100	$0.00	$0.00
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 242,776 shares (Direct); Common Stock — 6,847 shares (Indirect, By spouse); Common Stock — 5,000 shares (Indirect, By Padonia, LLC); Common Stock — 819 shares (Indirect, By Melvin Sharoky C/F Adler J. Wink UTMA/FL); Common Stock — 5,423 shares (Indirect, By Melvin Sharoky C/F Nolan M. Wink UTMA/FL); Common Stock — 5,007 shares (Indirect, By Melvin Sharoky C/F Sophie C. Wink UTMA/FL); Common Stock — 3,724 shares (Indirect, By Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL)

Holdings Before and After: Common Stock, 242,876 to 242,776 shares (Direct)

Footnotes (5)

1. F1. The Reporting Person is the managing member of Padonia, LLC.
2. F2. The Reporting Person is the custodian of Melvin Sharoky C/F Adler J. Wink UTMA/FL.
3. F3. The Reporting Person is the custodian of Melvin Sharoky C/F Nolan M. Wink UTMA/FL.
4. F4. The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.
5. F5. The Reporting Person is the custodian of Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did INSM director Melvin Sharoky report?

INSM director Melvin Sharoky, MD reported a bona fide gift of common stock. On March 3, 2026, an associated account transferred 100 shares of Insmed common stock as a gift at a reported price of $0.0000 per share, reducing his directly held balance.

How many INSMED Inc shares does Melvin Sharoky hold directly after the gift?

After the reported gift, Melvin Sharoky directly holds 242,776 Insmed common shares. This figure reflects his direct ownership position following the transfer of 100 shares classified as a bona fide gift on March 3, 2026, according to the Form 4 disclosure.

What indirect INSM shareholdings related to Melvin Sharoky are disclosed?

Indirectly, 6,847 Insmed shares are held by his spouse and 5,000 shares by Padonia, LLC, where he is managing member. Additional indirect holdings exist in multiple UTMA/FL custodial accounts for family beneficiaries, each with specific reported share balances on the same date.

What is Padonia, LLC’s role in Melvin Sharoky’s INSM holdings?

Padonia, LLC holds 5,000 Insmed common shares as an indirect ownership position for Melvin Sharoky. The filing states he is the managing member of Padonia, LLC, linking his beneficial interest to those shares while distinguishing them from his directly owned 242,776-share position.

Which UTMA/FL custodial accounts did Melvin Sharoky report for INSM shares?

Custodial UTMA/FL accounts show Insmed shares held for Adler J. Wink, Nolan M. Wink, Sophie C. Wink, and Tulia L. Sharoky. Reported balances are 819, 5,423, 5,007, and 3,724 shares respectively, with Sharoky disclosed as custodian for each account under Florida UTMA rules.

Was the reported INSM stock transfer a sale or a gift?

The reported Insmed stock transfer was a gift, not a sale. The Form 4 lists transaction code G, described as a “bona fide gift,” for 100 common shares at a stated price of $0.0000 per share, indicating a non-sale, no‑consideration disposition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SHAROKY MELVIN MD

(Last) (First) (Middle)

700 US HIGHWAY 202/206

(Street)

BRIDGEWATER NJ 08807

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INSMED Inc [ INSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		G		100	D	$0	242,776	D
Common Stock								6,847	I	By spouse
Common Stock								5,000	I	By Padonia, LLC(1)
Common Stock								819	I	By Melvin Sharoky C/F Adler J. Wink UTMA/FL(2)
Common Stock								5,423	I	By Melvin Sharoky C/F Nolan M. Wink UTMA/FL(3)
Common Stock								5,007	I	By Melvin Sharoky C/F Sophie C. Wink UTMA/FL(4)
Common Stock								3,724	I	By Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person is the managing member of Padonia, LLC.

2. The Reporting Person is the custodian of Melvin Sharoky C/F Adler J. Wink UTMA/FL.

3. The Reporting Person is the custodian of Melvin Sharoky C/F Nolan M. Wink UTMA/FL.

4. The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.

5. The Reporting Person is the custodian of Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL.

Remarks:

	/s/ Melvin Sharoky, M.D, by Michael A. Smith as Attorney-in-fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.